On August 10, 2005, the Federal Circuit affirmed the district court’s judgment that U.S. Patent No. 5,422,368, but not related U.S. Patent No. 5,296,504, which both related to a glaucoma drug marketed as Xalatan®, was - 504 - Document - PDFSEARCH.IO

First Page	Meta Content
	On August 10, 2005, the Federal Circuit affirmed the district court’s judgment that U.S. Patent No. 5,422,368, but not related U.S. Patent No. 5,296,504, which both related to a glaucoma drug marketed as Xalatan®, was Add to Reading List Document Date: 2005-08-25 11:14:36 Open Document File Size: 178,60 KB Share Result on Facebook Company Pharmacia Corp. / / / MedicalCondition glaucoma / / Person Lawrence M. Sung / / / Product Xalatan / / SocialTag Law Property law Ethics Inequitable conduct United States law Prior art Term of patent Patent Claim Patent law

On August 10, 2005, the Federal Circuit affirmed the district court’s judgment that U.S. Patent No. 5,422,368, but not related U.S. Patent No. 5,296,504, which both related to a glaucoma drug marketed as Xalatan®, wasAdd to Reading List